-
ChadTough Defeat DIPG advances research into epigenetics of pediatric brain cancer
The foundation's Game Changer Grant will enable concurrent genetic and epigenetic analysis to accelerate progress toward a cure.
-
The Dana-Farber Campaign
Your generosity has funded paradigm-shifting initiatives that lessen the burden of cancer for patients and families here and around the globe.
-
AACR targets breast and uterine cancers
The American Association for Cancer Research recently awarded more than $1 million in grants to Dana-Farber Cancer Institute investigators.
-
V Foundation boosts pediatric AML research
The V Foundation is taking aim at acute myeloid leukemia in children with a grant that will enhance Dana-Farber's search for more effective and durable treatments.
-
Breast Cancer Alliance
The Breast Cancer Alliance awarded a 2024 Young Investigator Grant of $125,000 to Sarah Naomi Olsen, PhD, accelerating her research on chromatin complexes in estrogen receptor-positive breast cancer. This impactful award will deepen our understanding of these unique complexes, laying the groundwork for new treatments which could significantly improve patient care.
-
Grants catalyze new advances in prostate cancer
The Prostate Cancer Foundation has awarded $1.45 million in grants to three Dana-Farber investigators researching more powerful treatments for the disease.
-
Tina’s Wish
Longtime supporter Tina’s Wish recently awarded more than $450,000 over a two-year period to support two Dana-Farber studies into early detection for ovarian cancer—one investigating a new class of microRNA and key biomarkers and how they could be used to develop a personalized blood test, and another examining how epigenetic alterations of fallopian tube epithelial…
-
V Foundation spurs pivotal research aimed at new epigenetic therapies
The V Foundation is spurring Dana-Farber Cancer Institute’s efforts to eradicate difficult-to-treat cancers through recent grants totaling $1.6 million awarded to two Dana-Farber investigators who aim to develop novel treatments known as epigenetic therapies.
-
Fallon gift helps advance epigenetic research
Real estate executive Mike Fallon wasn’t a cyclist or a Dana-Farber donor when David Fialkow invited him to a fundraising dinner for the Pan-Mass Challenge (PMC) in the spring of 2022.
-
What is epigenetics?
Patients around the world are counting on Dana-Farber to make cutting-edge discoveries and address the greatest mysteries in cancer research.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.